IR2022000371, NCT05453669: Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL |
|
|
| Recruiting | 1 | 12 | RoW | CD19-CAR-DNT cells | Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Ruijiamei Biotechnologies, Co., Ltd. | B-cell Non-Hodgkin's Lymphoma | 06/24 | 06/25 | | |
